Chatham Rock Phosphate Balance Sheet Health

Finanzielle Gesundheit Kriterienprüfungen 5/6

Chatham Rock Phosphate hat ein Gesamteigenkapital von CA$6.6M und eine Gesamtverschuldung von CA$0.0, was einen Verschuldungsgrad von 0% ergibt. Die Gesamtaktiva und Gesamtpassiva betragen CA$7.0M bzw. CA$412.2K.

Wichtige Informationen

Verhältnis von Schulden zu Eigenkapital

CA$0

Verschuldung

Zinsdeckungsgrad	n/a
Bargeld	CA$167.15k
Eigenkapital	CA$6.60m
Gesamtverbindlichkeiten	CA$412.17k
Gesamtvermögen	CA$7.01m

Jüngste Berichte zur Finanzlage

Recent updates

Analyse der Finanzlage

Kurzfristige Verbindlichkeiten: NZPDie kurzfristigen Aktiva des Unternehmens (CA$243.0K) decken seine kurzfristigen Passiva (CA$390.2K) nicht.

Langfristige Verbindlichkeiten: NZPDie kurzfristigen Vermögenswerte des Unternehmens (CA$243.0K) übersteigen seine langfristigen Verbindlichkeiten (CA$22.0K).

Geschichte und Analyse des Verhältnisses von Schulden zu Eigenkapital

Verschuldungsgrad: NZP ist schuldenfrei.

Schulden abbauen: NZP hatte vor 5 Jahren keine Schulden.

Bilanz

Liquiditätsreserve-Analyse

Bei Unternehmen, die in der Vergangenheit im Durchschnitt Verluste gemacht haben, wird geprüft, ob sie über einen Liquiditätsvorlauf von mindestens einem Jahr verfügen.

Stabile Start- und Landebahn für Bargeld: NZP verfügt auf der Grundlage des zuletzt gemeldeten freien Cashflows über eine ausreichende Liquiditätsreserve für 1 Monate. [freien Cashflow]], hat aber seitdem zusätzliches Kapital aufgenommen.

Vorhersage Cash Runway: Es wird prognostiziert, dass NZP auf Grundlage der Schätzungen des freien Cashflows über ausreichend Liquidität für 1 Monate verfügt, das Unternehmen hat seitdem jedoch weiteres Kapital aufgenommen.

Chatham Rock Phosphate Balance Sheet Health

Finanzielle Gesundheit Kriterienprüfungen 5/6

Wichtige Informationen

Jüngste Berichte zur Finanzlage

Chatham Rock Phosphate Limited Auditor Raises 'Going Concern' Doubt

Recent updates

Chatham Rock Phosphate Limited announced that it expects to receive NZD 0.59375 million in funding

Chatham Rock Phosphate Limited, Annual General Meeting, Nov 15, 2024

Chatham Rock Phosphate Limited announced that it has received NZD 0.140556 million in funding

Insufficient new directors

Third quarter 2024 earnings released: CA$0.004 loss per share (vs CA$0.003 loss in 3Q 2023)

Chatham Rock Phosphate Limited announced that it has received CAD 0.436294 million in funding

First half 2024 earnings released: CA$0.011 loss per share (vs CA$0.01 loss in 1H 2023)

Chatham Rock Phosphate Limited announced that it expects to receive CAD 0.7 million in funding

Chatham Rock Phosphate Limited Provides Update on Its Lead Project Korella North

Chatham Rock Phosphate Limited Announces Maiden Mineral Resource Estimate for the Korella North Phosphate Property in Queensland, Australia

New major risk - Revenue and earnings growth

Full year 2023 earnings released: CA$0.021 loss per share (vs CA$0.016 loss in FY 2022)

New minor risk - Shareholder dilution

Chatham Rock Phosphate Limited announced that it has received NZD 0.828591 million in funding

Chatham Rock Phosphate Limited Announces the Korella North Mine Planning and Marketing Advances

Third quarter 2023 earnings released: CA$0.003 loss per share (vs CA$0.006 loss in 3Q 2022)

Chatham Rock Phosphate Limited Announces Work Programme Approve for CRP's Pacific Rare Earths Selenium Exploration Permit At Gunnerside

Chatham Rock Phosphate Limited Grants Pacific Rare Earths Tambo Selenium Exploration Permit

Second quarter 2023 earnings released: CA$0.005 loss per share (vs CA$0.003 loss in 2Q 2022)

Chatham Rock Phosphate Limited Announces Approval from Queensland Department of Resources for Exploration Work in the Tambo Region of Central West Queensland

Chatham Rock Phosphate Limited Advances Korella North Project

Chatham Rock Phosphate Limited Announces Preliminary Phosphate Ore Sorting Results

First quarter 2023 earnings released: CA$0.005 loss per share (vs CA$0.004 loss in 1Q 2022)

Chatham Rock Phosphate Limited Continues to Enlarge Resource Asset Base with New Prospect in Queensland

Chatham Rock Phosphate Limited Applies for Korella North Exploration Permit

Full year 2022 earnings released: CA$0.016 loss per share (vs CA$0.017 loss in FY 2021)

Chatham Rock Phosphate Limited, Annual General Meeting, Nov 17, 2022

Chatham Rock Phosphate Limited Reports Encouraging Dicalcium Phosphate Test Results

Chatham Rock Phosphate Limited Provides Pacific Rare Earths Progress Report

Third quarter 2022 earnings: Revenues and EPS in line with analyst expectations

Second quarter 2022 earnings: Revenues and EPS in line with analyst expectations

Chatham Rock Phosphate Limited announced that it has received NZD 0.900125 million in funding from General Research GmbH

First quarter 2022 earnings released: CA$0.004 loss per share (vs CA$0.004 loss in 1Q 2021)

Chatham Rock Phosphate Limited announced that it expects to receive NZD 1.125 million in funding

High number of new directors

Full year 2021 earnings released: CA$0.017 loss per share (vs CA$0.025 loss in FY 2020)

Chatham Rock Phosphate Limited announced that it has received NZD 0.380812 million in funding

Chatham Rock Phosphate Limited (NZSE:CRP) completed the acquisition of Avenir Makatea Pty Ltd.

Chatham Rock Phosphate Limited announced that it has received NZD 0.72 million in funding

Third quarter 2021 earnings released: CA$0.003 loss per share (vs CA$0.005 loss in 3Q 2020)

Chatham Rock Phosphate Limited announced that it has received NZD 0.7 million in funding

Chatham Rock Phosphate Limited (NZSE:CRP) agreed to acquire Avenir Makatea Pty Ltd for CAD 1.5 million.

Chatham Rock Phosphate Limited announced that it expects to receive NZD 0.7 million in funding

Second quarter 2021 earnings released: CA$0.004 loss per share

First quarter earnings released

Chatham Rock Phosphate Limited Auditor Raises 'Going Concern' Doubt

Analyse der Finanzlage

Geschichte und Analyse des Verhältnisses von Schulden zu Eigenkapital

Bilanz

Liquiditätsreserve-Analyse

Entdecken Sie finanziell stabile Unternehmen